Possible COVID-19 “decoy”
by Bill Snyder
The novel coronavirus, SARS-CoV-2, must bind to the cell surface receptor ACE2 to enter cells and cause infection. Recently a preclinical study by an international research team found that the presence of a recombinant soluble form of human ACE2 reduced viral growth and inhibited infection.
This raises the possibility that ACE2 carried by extracellular vesicles or nanoparticles...